Triple-negative breast cancer (TNBC), which accounted for 15%–20% of all breast cancer patients [9], was a kind of breast cancer that lacked expression of estrogen receptor, progesterone receptor, or human epidermal growth factor receptor type 2 (HER2) [10]. This evidence concerns the gene ESR1 and breast carcinoma.